Baxter Q3 sales rise 5% to $2.84 billion; GAAP loss of $0.10 per share
Baxter reported third-quarter 2025 sales from continuing operations of $2.84 billion, up 5% on a reported basis, and adjusted diluted EPS of $0.69, up 41% from a year earlier. U.S. GAAP results were a loss, driven by $172 million of income tax expense, and the company set full-year 2025 adjusted EPS guidance of $2.35 to $2.40 while Andrew Hider joined as president and CEO.
Key points
- Q3 sales from continuing operations were $2.84 billion, up 5% reported and 2% operational; U.S. sales declined 1% operationally
- U.S. GAAP net loss from continuing operations was $51 million, or $0.10 per diluted share, including $172 million of income tax expense
- Full-year 2025 adjusted EPS guidance is $2.35 to $2.40; fourth-quarter guidance is $0.52 to $0.57
- Andrew Hider joined Baxter as president and CEO
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:12 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 30, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.